Cobalis Corp. (fka CLSC)

[urche]

I know a company with a better product----

and they could have bought it for a lot less than $54 million:


http://finance.yahoo.com/news/Par-pays-545-million-for-apf-14821309.html

Par pays $54.5 million for vitamin B12 drug
Par Pharmaceutical pays $54.5 million for rights to vitamin B12 deficiency treatment

* Wednesday April 1, 2009, 5:10 pm EDT

WOODCLIFF LAKE, N.J. (AP) -- Generic drug developer Par Pharmaceutical Cos. said Wednesday its Strativa unit bought worldwide rights to the vitamin B12 deficiency treatment Nascobal from QOL Medical for $54.5 million in cash.

Nascobal is a once-weekly nasal spray. Revenue exceeded $8 million in 2008.

Par also bought the facility where Nascobal is made.

Vitamin B12 deficiency can be caused by a range of conditions, including pernicious anemia, a strict vegetarian diet, and malabsorption of vitamin B12 resulting from conditions such as HIV infection, AIDS, Crohn's disease and multiple sclerosis.

Shares of Par fell 60 cents, or 6.3 percent, to close at $8.87. The stock has traded between $7.80 and $19.10 over the last 52 weeks.